Truist Securities Maintains Buy on Sabra Health Care REIT, Raises Price Target to $24
Sabra Health Care REIT, Inc.
Sabra Health Care REIT, Inc. SBRA | 0.00 |
Truist Securities analyst Michael Lewis maintains Sabra Health Care REIT (NASDAQ:
SBRA) with a Buy and raises the price target from $22 to $24.
